The move comes after a recent investigation found Chinese government procurement practices discriminate against EU companies ...

The companies scrapped the merger because securing FTC clearance “proved unviable in terms of time, expense and opportunity.” ...

Gaeta’s last role was a brief stint at Shockwave, which named her CFO two months before accepting J&J’s $13.1 billion ...

The startup received de novo authorization for the AI tool, the first of its kind that analyzes mammogram images to predict ...

Freenome plans to complete all modules of its premarket approval submission in mid-2025.

Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with ...

Smiths has not reported any serious injuries or deaths related to the issues, but the FDA sees a risk of harm.

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

The Trump Administration has effectively ended the Biden Administration's attempt to regulate lab-developed tests,” TD Cowen ...

IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of ...

The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.

Nvidia, which is already working with J&J and Medtronic, plans to partner with medtech companies to build platforms for ...